45th International Aldosterone Conference

Two Days of Powerful Talks

June 13 - 14, 2023

About the IAC

For over 40 years the IAC has remained the premier forum for the presentation and discussion of the latest research related to the study of aldosterone, corticosteroids, metabolizing enzymes and receptors in areas such as arterial and pulmonary hypertension, heart failure, atherosclerosis, and the metabolic syndrome.

It brings clinical, basic and translational researchers together to discuss the latest research in the field. This meeting is usually held annually as a satellite meeting of the Endocrine Society meeting.

The 45th International Aldosterone Conference meeting will take place in Chicago, IL and it will continue to provide the opportunity to meet and network with colleagues from across the world. The conference will feature a State-of-the-Art plenary lecture, free communications in oral and poster sessions, and a Young Investigators Award Program.

IAC 2023 Agenda

100 40+

7

Participants

Topics

Sessions

Speakers

IAC 2023 Speakers

C. Ronald Kahn, MD

C. Ronald Kahn, MD, is currently Chief Academic Officer at Joslin Diabetes Center and Mary K. Iacocca Professor of Medicine at Harvard Medical School. Kahn served as Research Director of Joslin from 1981-2000 and President/CEO from 2001-2007. Kahn is a world-recognized expert in diabetes and obesity research and the preeminent investigator of insulin signal transduction and mechanisms of altered signaling in metabolic disease. He has authored more than 800 articles and reviews, and has received more than 70 awards and honors, including election to the National Academy of Science, the Wolf Prize in Medicine, and honorary Doctorates from around the world. Find out more about Dr. Kahn here.

Iris Jaffe, MD, PhD

Iris Jaffe, MD, PhD is the Elisa Kent Mendelsohn Professor of Molecular Cardiology and Executive
Director of the Molecular Cardiology Research Institute (MCRI) at Tufts Medical Center, in Boston, MA
where she is also an attending Cardiologist. Dr. Jaffe received her BA in Biochemistry, PhD in Molecular
Biology, and MD degrees all at the University of Pennsylvania in Philadelphia. She completed her Internal
Medicine Residency training at Massachusetts General Hospital, clinical Cardiology fellowship at Brigham
and Women’s Hospital and Vascular Biology Research Fellowship in the MCRI at Tufts Medical Center,
all in Boston, MA. Iris joined the faculty at Tufts Medical Center in 2005 and was promoted to Professor of
Medicine at Tufts University School of Medicine in 2017. Dr. Jaffe’s research combines her background in
molecular and vascular biology with her interest as a clinical Cardiologist to explore molecular
mechanisms that contribute to common cardiovascular diseases with a goal of identifying novel
treatments. Her lab has specifically focused on the role of the aldosterone-responsive mineralocorticoid
receptor (MR) in blood vessels and demonstrated a direct contribution to hypertension, atherosclerosis,
vascular remodeling, vein graft failure, and pulmonary hypertension. Dr. Jaffe is the recipient of numerous
grants, awards and honors for her research discoveries, including the Established Investigator Award
from the American Heart Association and she is an elected member of the American Society of Clinical
Investigation (ASCI). Iris Jaffe has served as Associate Editor for Clinical Science and on the Editorial
Boards of Endocrinology and Hypertension. She is a standing member of the NIH Vascular Cell and
Molecular Biology (VCMB) Study Section which she currently chairs.

Massimiliano Caprio, MD, PHD

Massimiliano Caprio, MD, PHD is Professor of Endocrinology at San Raffaele Roma University, and is the head of the Laboratories of Cardiovascular Endocrinology at the Research Center of IRCCS San Raffaele Pisana in Rome. He has an internationally recognized expertise in the exploration of the roles of mineralocorticoid receptor (MR) activation in diabetes and metabolic syndrome. Prof. Caprio has contributed a large amount of work on the pathophysiology of adipose proliferation and endothelial inflammation due to excessive mineralocorticoid activation,Prof. Caprio is author of more than 115 publications in peer-reviewed journals, and has been often invited to give lectures by several academic institutions and meetings all over the world. He has been recipient of prestigious research grants as a PI: Fondation pour la Recherche Medical (France), Italian Ministery of Health , Italian Ministery of Foreign Affairs, Bayer Schering Pharma.

Fumitoshi Satoh, MD, PHD

Fumitoshi Satoh, MD, PHD received an M.D. in 1991 and a Ph.D. in 1997 both from Tohoku University. He completed a Research fellowship in the Department of Metabolic Medicine, Hammersmith Hospital, Imperial College of London, UK (Professor S.R. Bloom). Dr. Satoh is currently Professor; Division of Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Hospital.

C. Ronald Kahn, MD, is currently Chief Academic Officer at Joslin Diabetes Center and Mary K. Iacocca Professor of Medicine at Harvard Medical School. Dr. Kahn served as Research Director of Joslin from 1981-2000 and President/CEO from 2001-2007. Dr. Kahn is a world-recognized expert in diabetes and obesity research and the preeminent investigator of insulin signal transduction and mechanisms of altered signaling in metabolic disease. He has authored more than 800 articles and reviews, and has received more than 70 awards and honors, including election to the National Academy of Science, the Wolf Prize in Medicine, and honorary Doctorates from around the world. Find out more about Dr. Kahn here.

(State of the Art Lecture)

Iris Jaffe, MD, PhD is the Elisa Kent Mendelsohn Professor of Molecular Cardiology and Exec. Dir. of the Molecular Card. Research Institute (MCRI), Tufts Medical Center, in Boston, MA where she is also an attending Cardiologist. Dr. Jaffe received her BA in Biochemistry, PhD in Molecular Biology, and MD degrees all at the University of Pennsylvania in Philadelphia. She completed her Internal Medicine Residency training at Massachusetts General Hospital, clinical Cardiology fellowship at Brigham and Women’s Hospital and Vascular Biology Research Fellowship in the MCRI at Tufts Medical Center, all in Boston, MA. Iris joined the faculty at Tufts Medical Center in 2005 and was promoted to Professor of Medicine at Tufts University School of Medicine in 2017. Dr. Jaffe’s research combines her background in molecular and vascular biology with her interest as a clinical Cardiologist to explore molecular mechanisms that contribute to common cardiovascular diseases with a goal of identifying novel treatments. Her lab focuses on the role of the aldosterone-responsive mineralocorticoid receptor (MR) in blood vessels. Find out more about Dr. Iris Jaffe here.

Massimiliano Caprio, MD, PhD is Professor of Endocrinology at San Raffaele Roma University, and is the head of the Laboratories of Cardiovascular Endocrinology at the Research Center of IRCCS San Raffaele Pisana in Rome. He has an internationally recognized expertise in the exploration of the roles of mineralocorticoid receptor (MR) activation in diabetes and metabolic syndrome. Prof. Caprio has contributed a large amount of work on the pathophysiology of adipose proliferation and endothelial inflammation due to excessive mineralocorticoid activation,Prof. Caprio is author of more than 115 publications in peer-reviewed journals, and has been often invited to give lectures by several academic institutions and meetings all over the world. He has been recipient of prestigious research grants as a PI: Fondation pour la Recherche Medical (France), Italian Ministery of Health , Italian Ministery of Foreign Affairs, Bayer Schering Pharma.

(Senior Investigator presentation)

Fumitoshi Satoh, MD, PHD received an M.D. and a Ph.D. in 1987 both from Tohoku University. He completed a Research fellowship in the Department of Metabolic Medicine, Hammersmith Hospital, Imperial College of London, UK (Professor S.R. Bloom). Dr. Satoh is currently Professor; Division of Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Hospital.